Skip to main content
. 2023 Nov 14;7:41. doi: 10.1186/s41927-023-00365-4

Table 3.

Predictors for employment among patients with RA

Predictor Studies Participants Chi2 p I2 (%) OR 95% CI
Age (< = 50/ > 50 years) 5 2623 74.4  < 0.001 95 3.56 2.97, 4.26
Gender (female/male) 28 16248 74.1  < 0.001 64 0.58 0.53, 0.62
Educational level (college/below college) 14 5117 20.2 0.09 35 2.25 1.96, 2.59
Race (Caucasian/not Caucasian) 8 3197 12.0 0.10 42 1.13 0.90, 1.42
Job type (not manual/manual) 8 2366 13.8 0.06 49 2.38 1.89, 3.00
Comorbidities (not present/present) 4 1932 4.2 0.25 28 1.74 1.41, 2.14
MTX ever (no/yes) 5 3191 5.44 0.25 26 0.87 0.73, 1.03
Biological treatment ever (no/yes) 6 11960 132  < 0.001 96 0.89 0.81, 0.98
Prednisolone ever (no/yes) 2 633 1.05 0.3 5 0.41 0.25, 0.68
Predictor Studies Participants Mean difference 95% CI
Age (low/high age) 17 4361 -6.59 -7.03, -6.15
Disease duration (short/long) 8 1998 -1.54 -2.05, -1.03
HAQ score (low/high) 5 1652 -0.48 -0.55, -0.40
Joint pain, VAS score (low/high) 4 906 -0.92 -1.25, -0.59
SF 36 (low/high) 2 309 7.57 5.03, 10.1
DAS 28 (low/high) 2 568 -0.27 -0.48, -0.06